Overexpression of CCN3 in a human CML cell line resulted in a reduction in clonogenicity, increase in apoptosis and reduction in phosphorylation of Erk2 (McCallum et al. 2012). The gene discussed is CCN3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.